SynthesisTargeted oncology2026

Chimeric Antigen Receptor-T Cell Therapy for Pediatric and Young Adult Primary Central Nervous System Tumors: A Systematic Review of Early Phase Clinical Trials with a Focus on Diffuse Midline Glioma.

Sai Sanikommu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.